Company intelligence / Profile preview

Transcendent International

New York City, New York, United Statessbir.gov ↗

Ownership: Private
Employees: ~24
Development stage: Other

Overview

Transcendent International develops technology-enabled solutions to address communication barriers, language access, and social determinants of health. Their products include decision-support tools for healthcare administrators to improve patient attendance through better transportation logistics, language translation support for medical professionals, and culturally relevant educational materials to address nutrition-related health disparities[3][10].

Therapeutic areas: Metabolic DisordersOther
Modalities: DeviceSoftwareNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

U.S. National Institutes of Health/NICHD/HHS via multiple SBIR grants[3][10]

Beyond the preview

Go deeper on Transcendent International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcendent International.

Explore the full profile